AdAlta is pleased to share with you our December 2017 Shareholder Update. AdAlta has had a solid year of execution in 2017, ticking the various boxes required to take AD-114 into the clinic.
AdAlta is looking forward to progressing AD-114 into the clinic in 2018, if you would like to keep up to date with progress, sign up to be an AdAlta subscriber here.